ENDPOINTS

AstraZeneca agrees to pay $51M to settle ‘pay-for-delay’ class action suit

AstraZeneca and Handa Pharmaceuticals have agreed to pay a combined $51.4 million to resolve a class action lawsuit that claimed they unlawfully delayed the availability of cheaper generic versions of AstraZeneca’s antipsychotic drug. The lawsuit ...

May 30, 2025 - 19:54
 0
AstraZeneca agrees to pay $51M to settle ‘pay-for-delay’ class action suit
AstraZeneca and Handa Pharmaceuticals have agreed to pay a combined $51.4 million to resolve a class action lawsuit that claimed they unlawfully delayed the availability of cheaper generic versions of AstraZeneca’s antipsychotic drug. The lawsuit ...
Read More

Tags:

Previous Article

New CDC vaccine schedule at odds with HHS announcement

Next Article

C.D.C. Contradicts Kennedy and Keeps Advice That Children May Get Covid Shots

Related Posts

Optura raises $6.5M to help evaluate healthcare AI programs

Optura raises $6.5M to help evaluate healthcare AI prog...

May 20, 2025  0

FDA adcomm votes unanimously against Pfizer's prostate cancer drug combo

FDA adcomm votes unanimously against Pfizer's prostate ...

May 22, 2025  0

FDA warns Mayne Pharma over 'misleading' birth control pill claims

FDA warns Mayne Pharma over 'misleading' birth control ...

May 15, 2025  0